Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...

After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, ...

HARTFORD— This week, the CEO of CVS Health expressed confidence that the company would turn around its embattled health-insurance business, the Hartford- based Aetna. CVS' reputation in Connecticut ...

CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...

Shares of CVS Health (CVS) surged Wednesday morning after the health insurance and pharmacy giant reported ...

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best ...

Troubled drugstore chain CVS Health (CVS) reported Fiscal fourth-quarter results that beat on the top and bottom lines, ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The drugstore chain and pharmacy benefits manager earned $1.64 billion ...